WASHINGTON (AP) -- Health regulators reiterated their warning Friday that organ transplant drugs from Roche and Novartis can cause miscarriages and birth defects when used by pregnant women....
... YORK (Reuters) - Swiss pharmaceutical company Roche Holding AG will suspend its HIV research ...
Roche said it would pay a lower price than it had offered last July for the 44 percent of Genentech it does not already own and that it would go directly to shareholders with its offer.
... as it made its case to Wall Street on what it considers a low buyout bid from drugmaker Roche ...
GENEVA (AP) -- Swiss pharmaceutical giant Roche said Thursday it has agreed to buy California-based Genentech for $46.8 billion in a takeover described as the largest in Swiss corporate history....
... Therapeutics Ltd signed a research and license option deal with Roche Holding AG, granting Roche rights to investigate the potential of its ICT-69 antibody in the diagnosis and treatment of multiple myeloma ...
... trial rulesThe pharmaceutical firms Novartis and Roche have threatened to pull out of Britain and relocate thousands ... people in Britain at nine sites while Roche has 1,500 workers in this country.The ministers ...
Roche agreed to pay up to $1.1 billion to Aileron Therapeutics, which is developing a new type of drug technology called stapled peptides.
... agreement between UCLA and Roche will provide stem cell and cancer researchers with leading-edge technologies ...
The Swiss pharmaceutical giant Roche on Tuesday begins a two-day appeal asking the US Food and Drug Administration to allow the top-selling drug Avastin to be used for breast cancer.
US health officials on Friday revoked the authorization of Roche's Avastin for breast cancer treatment, saying it concluded the drug had "not been shown to be safe and effective for that use."
... of side effects. When previously questioned by the BMJ, Roche also admitted that some of the published papers had been ghost written ... on an antibody response to be effective. But when asked by the BMJ, Roche refused to explain how the drug works. As such, the Cochrane ...
Roche aims to expand personalised medicine diagnostics by acquiring the gene sequencing leader
Roche takeover bid poses challenge to IlluminaNature News , 31012012 doi: 10.1038/nature.2012.9928Erika Check HaydenA merger could stifle innovation, say observers.
Swiss drug giant Roche said on Monday it had been given European Union approval for its treatment to fight a highly aggressive form of skin cancer.
